GlassScriptPhysician profile
Joysree Subramanian
NPI 1215943949
$8,814.07
in general payments reported to CMS, 2019-2025
8 companies · $2,774 in 2025
The $2,774 reported for 2025 was more than what 87% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $2,151 · 2021: $163 · 2022: $2,690 · 2023: $750 · 2024: $80.81 · 2025: $2,774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,209 · Travel and Lodging: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,209.06 |
| Travel and Lodging | $1,395.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,370.38 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept Rf Probe |
| Medtronic, INC. | $1,371.32 | 2023-2025 | Synchromedii, Intellis Adaptivestim, Vanta Adaptivestim |
| Spinal Simplicity, LLC | $1,188.19 | 2022 | |
| Stimwave Technologies Incorporated | $1,032.28 | 2021-2022 | |
| Spr Therapeutics, INC | $812.01 | 2022-2025 | Sprint Pns System |
| Flowonix Medical Incorporated | $694.01 | 2020 | |
| Medtronic USA, INC. | $287.58 | 2019-2020 | |
| Vertiflex, INC. | $58.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joysree Subramanian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.